TGFB1 and COVID-19: Recently, Laloglu and Alay (2022) reported that in patients with confirmed COVID-19 and pulmonary involvement, along with elevated connective tissue growth factor levels, significantly high concentrations of TGF-β1 in serum samples were noted, especially in more severe pneumonia groups [255].